logo

2.32

2.32 (-1.21%)

As of Mar 06, 2024

Processa Pharmaceuticals, Inc. [PCSA]

Source: 

Company Overview

Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on utilizing the Processa Regulatory Science Approach, including the principles associated with FDA’s Project Optimus Oncology initiative and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy oncology drug products.

CountryUnited States
Headquartershanovermaryland
Phone Number443-776-3133
Industry
manufacturing
CEODavid Young
Websitewww.processapharmaceuticals.com